News

“The model for funding academic research was insufficient, inefficient and ineffective” said Cure Alzheimer’s Fund co-founder and venture capitalist Henry McCance.

Posted: May 19, 2011

In Science/Business article CAF's Henry McCance discusses how he used his venture capital expertise to take on finding a cure for Alzheimer's after his wife was diagnosed with the disease 10 years ago.

McCance co-founded Cure Alzheimer's Fund  explaining “the model for funding academic research was insufficient, inefficient and ineffective.” McCance hopes this concept of venture research will catch on.

Read article here

 

NY Times online column highlights Cure Alzhemer's Fund's innovative approach to research

Posted: May 16, 2011

NY Times online columnist David Bornstein examines how the Cure Alzheimer's Fund and other organizations have taken a unique approach to research that is intensely goal-directed and collaborative, focusing on the creation of new cures and potential treatment as a process that needs to be managed. Bornstein notes the Fund has worked to bring a sense of urgency to their research that is resulted oriented.

Read more

USA Today online features Cure Alzheimer's grant to Nobel Lauerate Paul Greengard

Posted: May 16, 2011

Cure Alzheimer's Fund's $100,000 grant to Rockefeller University's Dr. Paul Greengard was featured in USA Today online "Charity in the News: Week in Review." The Nobel Laureate will use the grant to continue his studies on identifying brains cells that are vulnerable to Alzheimer’s. His studies could lead to the development of protective drugs targeted at those specific cells.

Read more here

 

Support the Coast-to-Coast Solo Run to Cure Alzheimer’s

Posted: May 13, 2011

Photo of Glenn Caffery

On May 19, 2011, Glenn Caffery, age 49, set out from Seaside, Ore., to run 3,312 miles across the country to Westerly, R.I. He is running to honor his father—Dick Caffery—whom he lost to Alzheimer’s disease in 2002, and to raise money to help find a cure for this devastating illness. “Watching my father suffer made me feel so helpless,” says Caffery. “Since he’s passed away, I’ve felt like I needed to do something to help, and running across the country felt like something.”

Coast-to-Coast Solo Run to Cure Alzheimer’s

Posted: May 11, 2011

Distance Runner to Raise Awareness, Research Funding for Alzheimer’s on 3,300-Mile Journey from Oregon to Rhode Island

Seaside, Oregon – Setting out on a 3,300-mile run from Seaside, Ore., to Westerly, R.I. to raise money and public awareness of Alzheimer’s disease, veteran distance runner and advocate Glenn Caffery compares the rigors of long distance running to the challenges facing 5.2 million Americans and their families who are dealing with the debilitating disease.

Alzheimer’s Association- a new beneficiary of The 7 Summits Climb for Alzheimer’s campaign

Posted: May 11, 2011

The 7 Summits Climb for Alzheimer’s: Memories are Everything is a year-long challenge by mountain climber and Alzheimer’s disease advocate Alan Arnette to scale the 7 summits, the highest peak on each continent. Alan is striving to raise $1 million to advance Alzheimer’s research, and provide support for family caregivers and all those affected by Alzheimer’s disease.

Rockefeller University Nobel Laureate awarded Cure Alzheimer's Fund research grant

Posted: May 11, 2011

Nobel laureate Paul Greengard, a Rockefeller University professor has been awarded a $100,000 grant by Cure Alzheimer’s Fund to continue his groundbreaking research on Alzheimer’s disease, the most common cause of dementia in the elderly that currently affects 5.2 million Americans and their families.

Paul Greengard, Ph.D., will use the grant to continue his studies on identifying brains cells that are vulnerable to Alzheimer’s. His studies could lead to the development of protective drugs targeted at those specific cells.

Cure Alzheimer’s Fund Awards Grant to University of Virginia for Innovative Research

Posted: Apr. 27, 2011

Boston - A University of Virginia professor has been awarded a $100,000 grant by Cure Alzheimer’s Fund to continue his groundbreaking research on Alzheimer’s disease, the most common cause of dementia in the elderly, which currently affects 5.2 million Americans and their families.

George S. Bloom, Ph.D., will use the grant to continue his studies on a strain of antibodies thought to be able to recognize the proteins associated with Alzheimer’s.

Larry King highlights Alzheimer’s epidemic on CNN special Sunday, May 1

Posted: Apr. 25, 2011

CNN will be airing the Larry King special “Unthinkable: the Alzheimer’s Epidemic” on Sunday, May 1 at 8:00 PM in most time zones. King will explore Alzheimer’s disease, the people it affects, its impact on their families, the latest in treatment, and why it is critical to find a cure for this devastating disease.

CAF's Dr. Tanzi on the latest on Alzheimer's Disease Genes

Posted: Apr. 18, 2011

The Four Known Alzheimer’s Genes